Ha Olofsson

Ha Olofsson has extensive experience in regulatory affairs, currently serving as the EU Regulatory Lead at Sobi - Swedish Orphan Biovitrum AB (publ) since March 2019, and has held the position of Director Global Regulatory Affairs (acting) as well as Global Regulatory Manager. Prior to this, Ha contributed as a Consultant at NDA Group AB from May 2010 to April 2019, and held managerial roles at GlaxoSmithKline from August 2004 to May 2010, as well as at Pfizer from August 2002 to August 2004. Ha Olofsson holds a degree in Pharmacy from Uppsala University, obtained between 1992 and 1996.